Lifecore Biomedical, Inc. Class Action Lawsuit - LFCR

Company
Lifecore Biomedical, Inc. (NASDAQ: LFCR)
Class Period
July 19, 2019 - July 19, 2024

Never Miss Another Deadline

Choose your preferred way to stay informed of new case launches and settlement deadlines

WhatsApp

Scan the QR code or click the button to join

Join on WhatsApp

Get Updates by Email

Required Field

Required Field

Required Field

No Spam, opt-out anytime, alert list is free

Allegations

Lifecore announced on March 20, 2024, that its Board of Directors had concluded its review of strategic alternatives, in which it "unanimously concluded that the best way to maximize value for stockholders at this time is to continue executing on the Company's standalone strategic plan." The Company also announced a leadership transition by naming a new CEO. Following this news, shares of Lifecore dropped over 35% in morning trading on the same day.

Eligibility

In order to be eligible to join the LFCR class action lawsuit, you must have incurred a loss on shares of Lifecore purchased during the class period listed above.

TOP